p59fyn is associated with the development of hepatic steatosis due to chronic ethanol consumption

Journal of Clinical Biochemistry and Nutrition

Volumn 49, Issue 1, 2011, Pages 20-24

  Fukunishi, Shinya ^a   Tsuda, Yasuhiro ^a   Takeshita, Atsushi ^a   Fukui, Hideo ^a   Miyaji, Katsuhiko ^a   Fukuda, Akira ^a   Higuchi, Kazuhide ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Chronic ethanol consumption; Fatty acid oxidation; Interleukin 6; p59fyn; Steatosis

Indexed keywords

INTERLEUKIN 6; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE P59FYN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FATTY ACID METABOLISM; FATTY LIVER; HISTOPATHOLOGY; LIVER LEVEL; MALE; MOUSE; NONHUMAN; PATHOGENESIS;

MUS;

EID: 79959932859     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.10-115     Document Type: Article

References (24)

1. cdc2 is a specific and efficient substrate of src-family tyrosine kinases. J Bio Chem 1992; 267: 9248-9256.
2. Migita K, Eguchi K, Kawabe Y, Mizokami A, Tsukada T, Nagataki S. Prevention of anti-CD3 monoclonal antibody-induced thymic apoptosis by protein tyrosine kinase inhibitors. J Immunol 1994; 153: 3457-3465. (Pubitemid 24313848)
3. fynT. J Bio Chem 1996; 271: 5968-5971.
4. Schlottmann KE, Gulbins E, Lau SM, Coggeshall KM. Activation of src-family tyrosine kinases during Fas-induced apoptosis. J Leuko Biol 1996; 60: 546-554. (Pubitemid 26356782)
5. Ricci JE, Maulon L, Luciano F, and et al. Cleavage and relocation of the tyrosine kinase P59FYN during Fas-mediated apoptosis in T lymphocytes. Oncogene 1999; 18: 3963-3969. (Pubitemid 29361334)
6. Luciano F, Ricci JE, Auberger P. Cleavage of Fyn and Lyn in their N-terminal unique regions during induction of apoptosis: a new mechanism for Src kinase regulation. Oncogene 2001; 20: 4935-4941. (Pubitemid 32769783)
7. Ricci JE, Lang V, Luciano F, and et al. An absolute for Fyn in T cell receptor-induced caspase activation and apoptosis. FASEB J 2001; 15: 1777-1779.
8. Miyakawa T, Yagi T, Kitazawa H, and et al. Fyn-kinase as determinant of ethanol sensitivity: relation to NMDA-receptor function. Science 1997; 278: 698-701. (Pubitemid 27464970)
9. Bastie CC, Zong H, Xu J, and et al. Integrative metabolic regulation of peripheral tissue fatty acid oxidation by the SRC kinase family member Fyn. Cell Metab 2007; 5: 371-381. (Pubitemid 46679518)
10. Stein PL, Lee HM, Rich S, Soriano P. pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell 1992; 70: 741-750.
11. Hong F, Radaeva S, Pan HN, Tian Z, Veech R, Gao B. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease. Hepatology 2004; 40: 933-941. (Pubitemid 39288127)
12. Martinez F, Abril ER, Earnest DL, Watson RR. Ethanol and cytokines secretion. Alcohol 1992; 9: 455-458.
13. Diehl AM. Cytokines and the molecular mechanisms of alcoholic liver disease. Alcohol Clin Exp Res 1999; 23: 1419-1424. (Pubitemid 29468436)
14. Laso FJ, Iglesias-Osma C, Ciudad J, Lopez A, Pastor I, Orfao A. Chronic alcoholism is associated with an imbalanced production of Th-1/Th-2 cytokines by peripheral blood T cells. Alcohol Clin Exp Res 1999; 23: 1306-1311. (Pubitemid 29409343)
15. McClain CJ, Barve S, Deaciuc I, Kugelmas M, Hill D. Cytokines in alcoholic liver disease. Semin Liver Dis 1999; 19: 205-219.
16. Nanji AA, Zhao S, Sadrzadeh SM, Waxman DJ. Use of reverse transcrition-polymerase chain reaction to evaluate in vivo cytokine gene exprssion in rats fed ethanol for long periods. Hepatology 1994; 19: 1483-1487. (Pubitemid 24166472)
17. McClain CJ, Barve S, Deaciuc I, Hill DB. Tumor necrosis factor and alcoholic liver disease. Alcohol Clin Exp Res 1998; 22: 703-721.
18. Cressman DE, Greenbaum LE, DeAngelis RA, and et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-1383. (Pubitemid 26391463)
19. Kovalovich K, DeAngelis R, Li W, Furth EE, Ciliberto G, Taub R. Increased toxin-induced liver injury and fibrosis in interleukin-6-deficient mice. Hepatology 2000; 31: 149-159. (Pubitemid 30033701)
20. Kovalovich K, Li W, DeAngelis R, Greenbaum LE, Ciliberto G, Taub R. Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic protein FLIP, Bcl-2, and Bcl-xL. J Biol Chem 2001; 276: 26605-26613.
21. Panesar N, Tolman K, Mazuski JE. Endotoxin stimulates hepatocyte interleukin-6 production. J Surg Res 1999; 85: 251-258. (Pubitemid 29372331)
22. Kolvea M, Schlaf G, Landmann R, Götze O, Jungemann K, Schieferdecker HL. Induction of anaphylatoxin C5a receptors in rat hepatocytes by lipopolysaccharide in vivo: mediation by interleukin-6 from Kupffer cells. Gastroenterology 2002; 122: 697-708. (Pubitemid 34173822)
23. Leevy CM. Fatty liver: a study of 270 patients with biopsy proven fatty liver and review of the literature. Medicine 1962; 41: 249-276.
24. Omagari K, Morikawa S, Nagaoka S, and et al. Predictive factors for the development or regression of fatty liver in Japanese adults. J Clin Biochem Nutr 2009; 45: 56-67.